Home » Newsletters » BioWorld Asia

BioWorld Asia

March 29, 2000

View Archived Issues

Actelion Files For 1M-share IPO On Swiss New Market

Axxima completes DM20 Million Financing For Anti-Infectives

Researchers Find Hippocampi Area Of Adult Brain Can Grow

Matrix begins DO2 trial

European Court Deals Another Blow To Clarity On Biotech

Toronto Researchers Discover Gene Regulating Cancer Growth

Survey shows European skepticism over GM foods grows

Israeli Biotechnology Seen As Opportunity Not To Be Missed

Promise Of Gains In Genetic Research Raises Firm's Shares

Despite Market Falloff, Transghne Still Plans To Carry Out Offering

Peptide Therapeutics To Sell Its Drug Discovery Unit To Medivir

Scotia Talking With Possible Partners On Foscan PDT

Eurogen Moving Collar Device For Gene Delivery Into Phase I

Other News To Note

Sweden's Karo Bio In Agreement To Buy Novalon, U.S. Biotech Firm

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...